Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma.
作者信息
Becher R, Kloke O, Höffken K, Scheulen M E, Wandl U B, Bojar H, Schmidt C G
机构信息
Innere Klinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, Federal Republic of Germany.
出版信息
Br J Cancer. 1989 Jun;59(6):948. doi: 10.1038/bjc.1989.201.
Abstract
摘要
相似文献
1
Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma.高剂量醋酸甲羟孕酮治疗晚期恶性黑色素瘤的II期研究
Br J Cancer. 1989 Jun;59(6):948. doi: 10.1038/bjc.1989.201.
2
Phase II study of oral medroxyprogesterone acetate in advanced germ cell tumors.醋酸甲羟孕酮治疗晚期生殖细胞肿瘤的II期研究。
Cancer Treat Rep. 1983 Oct;67(10):953-4.
3
High-dose medroxyprogesterone acetate in patients with renal adenocarcinoma and measurable lung metastases: a phase II study.高剂量醋酸甲羟孕酮治疗肾腺癌伴可测量肺转移患者：一项II期研究。
Cancer Treat Rep. 1986 Mar;70(3):431-2.
4
Endocrine treatment with anti-estrogen, anti-androgen or progestagen of advanced malignant melanoma: three consecutive phase II trials.晚期恶性黑色素瘤的抗雌激素、抗雄激素或孕激素内分泌治疗：三项连续的II期试验。
Eur J Cancer Clin Oncol. 1985 Oct;21(10):1171-4. doi: 10.1016/0277-5379(85)90010-0.
5
High-dose medroxyprogesterone in the treatment of advanced therapy-resistant prostatic carcinoma.大剂量甲羟孕酮治疗晚期难治性前列腺癌。
Eur Urol. 1985;11(1):9-10. doi: 10.1159/000472440.
6
Prevention of postmenopausal bone loss and endometrial responses during a two year prospective study with transdermal 17 beta-estradiol and oral medroxyprogesterone acetate.在一项为期两年的前瞻性研究中，使用经皮17β-雌二醇和口服醋酸甲羟孕酮预防绝经后骨质流失及子宫内膜反应。
Ann N Y Acad Sci. 1991;622:302-6. doi: 10.1111/j.1749-6632.1991.tb37875.x.
7
8
Oral plus intramuscular medroxyprogesterone acetate (high dose Farlutal) in advanced breast cancer.
Southeast Asian J Trop Med Public Health. 1985 Dec;16(4):634-7.
9
High dose versus low dose medroxyprogesterone acetate: a randomized trial in advanced breast cancer.高剂量与低剂量醋酸甲羟孕酮：晚期乳腺癌的一项随机试验
Eur J Cancer Clin Oncol. 1987 Dec;23(12):1895-900. doi: 10.1016/0277-5379(87)90056-3.
10
High-dose medroxyprogesterone acetate versus prednisolone in hormone-resistant prostatic cancer. A pilot study.高剂量醋酸甲羟孕酮与泼尼松龙治疗激素抵抗性前列腺癌的对比：一项初步研究
Eur Urol. 1985;11(1):11-6. doi: 10.1159/000472441.
本文引用的文献
1
Estrogen and progesterone receptors and tamoxifen in malignant melanoma.恶性黑色素瘤中的雌激素和孕激素受体以及他莫昔芬
Cancer Treat Rep. 1980 Jun-Jul;64(6-7):819-27.
2
Receptor for glucocorticoids in RPMI 3460 melanoma cells.RPMI 3460黑色素瘤细胞中的糖皮质激素受体。
Cancer Res. 1980 Jul;40(7):2174-8.
3
Gradient centrifugation analysis of steroid-hormone binding in human malignant melanoma.人恶性黑色素瘤中类固醇激素结合的梯度离心分析
Anticancer Res. 1982 Jul-Aug;2(4):245-9.
4
Phase II study of high-dose megestrol acetate in patients with advanced malignant melanoma.醋酸甲地孕酮高剂量治疗晚期恶性黑色素瘤患者的II期研究。
Cancer Treat Rep. 1982 May;66(5):1239-40.
5
High incidence and characterization of glucocorticoid receptors in human malignant melanoma.人类恶性黑色素瘤中糖皮质激素受体的高发生率及特征
J Natl Cancer Inst. 1981 Jan;66(1):21-5.
Zotero 插件